Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Annals of Neurology
|
June 1, 1980
Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations
L J Thal, N S Sharpless, L Wolfson, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1983
Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa
G M Tyce, J Stockard, N S Sharpless, et al.
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1985
Biogenic amine alterations in limbic brain regions of muricidal rats
P A Broderick, G A Barr, N S Sharpless, et al.
Brain Research
|
January 1, 1987
Age-related changes in striatal dopamine activity following nigral muscimol infusions
S L Moshé, E F Sperber, J N Wurpel, et al.
Mayo Clinic Proceedings
|
March 1, 1977
Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease
M D Muenter, N S Sharpless, G M Tyce, et al.
Annals of Neurology
|
May 1, 1983
Oral physostigmine and lecithin improve memory in Alzheimer disease
L J Thal, P A Fuld, D M Masur, et al.
Pharmacology, Biochemistry, and Behavior
|
April 1, 1989
Intranigral GABAergic drug effects on striatal dopamine activity
E F Sperber, J N Wurpel, N S Sharpless, et al.
Neurology
|
March 1, 1983
Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia
L I Wolfson, N S Sharpless, L J Thal, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1986
Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease
L J Thal, D M Masur, N S Sharpless, et al.
Biochemical Pharmacology
|
November 15, 1983
Striatal met-enkephalin concentration increases following nigrostriatal denervation
L J Thal, N S Sharpless, I D Hirschhorn, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Annals of Neurology
|
June 1, 1980
Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations
L J Thal, N S Sharpless, L Wolfson, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1983
Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa
G M Tyce, J Stockard, N S Sharpless, et al.
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1985
Biogenic amine alterations in limbic brain regions of muricidal rats
P A Broderick, G A Barr, N S Sharpless, et al.
Brain Research
|
January 1, 1987
Age-related changes in striatal dopamine activity following nigral muscimol infusions
S L Moshé, E F Sperber, J N Wurpel, et al.
Mayo Clinic Proceedings
|
March 1, 1977
Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease
M D Muenter, N S Sharpless, G M Tyce, et al.
Annals of Neurology
|
May 1, 1983
Oral physostigmine and lecithin improve memory in Alzheimer disease
L J Thal, P A Fuld, D M Masur, et al.
Pharmacology, Biochemistry, and Behavior
|
April 1, 1989
Intranigral GABAergic drug effects on striatal dopamine activity
E F Sperber, J N Wurpel, N S Sharpless, et al.
Neurology
|
March 1, 1983
Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia
L I Wolfson, N S Sharpless, L J Thal, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1986
Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease
L J Thal, D M Masur, N S Sharpless, et al.
Biochemical Pharmacology
|
November 15, 1983
Striatal met-enkephalin concentration increases following nigrostriatal denervation
L J Thal, N S Sharpless, I D Hirschhorn, et al.
Page
of 3